How IFN-γ Causes Rejection of Stem Cell Transplants in Certain Patients
Author Information
Author(s): Martin Rottman, Claire Soudais, Guillaume Vogt, Laure Renia, Jean-François Emile, Hélène Decaluwe, Jean-Louis Gaillard, Jean-Laurent Casanova
Primary Institution: Laboratoire de Génétique Humaine des Maladies Infectieuses, INSERM, U550, Paris, France
Hypothesis
Is high serum IFN-γ concentration responsible for graft rejection in IFN-γR1-deficient hosts?
Conclusion
High serum IFN-γ concentration is necessary and sufficient for graft rejection in IFN-γR1-deficient mice.
Supporting Evidence
- IFN-γ levels were high in Ifngr1−/− mice infected with BCG before HSCT.
- Transplantation was successful in Ifngr1−/− × Ifng−/− double-mutant mice, even after BCG infection.
- Efficient antibody-mediated IFN-γ depletion allowed subsequent engraftment in infected Ifngr1−/− mice.
Takeaway
This study found that too much of a certain protein, IFN-γ, in the blood can stop stem cell transplants from working in mice that lack a specific receptor. This might help doctors figure out how to make transplants work better for people with similar issues.
Methodology
The study used a mouse model to investigate the effects of IFN-γ on HSCT rejection, including various experimental infections and treatments.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Statistical Information
P-Value
p ≤ 0.007
Statistical Significance
p ≤ 0.007
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website